Long-term levodopa admnistration in chronic stroke patients. A clinical and neurophysiologic single-blind placebo-controlled cross-over pilot study

Restorative Neurology and Neuroscience

Volumn 27, Issue 4, 2009, Pages 277-283

  Acler, M ^a   Fiaschi, A ^a   Manganotti, P ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

Drug; Levodopa; Rehabilitation; Stroke; TMS

Indexed keywords

CARBIDOPA; LEVODOPA; PLACEBO;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC STROKE; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; EVOKED CORTICAL RESPONSE; EVOKED MUSCLE RESPONSE; EXCITABILITY; FEMALE; HAND; HEMISPHERE; HUMAN; LONG TERM CARE; MALE; MEMBRANE STEADY POTENTIAL; MOTOR PERFORMANCE; MUSCLE STIFFNESS; NAUSEA; NEUROPHYSIOLOGY; PHYSIOTHERAPY; PILOT STUDY; PRIORITY JOURNAL; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; STROKE; STROKE PATIENT; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT DURATION; TREATMENT OUTCOME; VOMITING; WALKING; WALKING SPEED;

AGED; AGED, 80 AND OVER; BIOPHYSICAL PROCESSES; CROSS-OVER STUDIES; DOPAMINE AGENTS; ELECTRIC STIMULATION; ELECTROMYOGRAPHY; EVOKED POTENTIALS, MOTOR; FEMALE; FUNCTIONAL LATERALITY; HUMANS; LEVODOPA; MALE; MIDDLE AGED; MOTOR ACTIVITY; PILOT PROJECTS; SINGLE-BLIND METHOD; STATISTICS, NONPARAMETRIC; STROKE; TIME FACTORS; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 70349157220     PISSN: 09226028     EISSN: None     Source Type: Journal    
DOI: 10.3233/RNN-2009-0477     Document Type: Article

References (35)

1. Paolucci, S., & De Angelis, D. (2006). New developments on drug treatment rehabilitation. Clin Exp Hypertension, 28, 345-348.
2. Gladstone, D. J., & Black S. E. (2000). Enhancing recovery after stroke with noradrenergic pharmacotherapy: a new frontier? Can J Neurol Sci, 27, 97-105.
3. Martinsson, L., Wahlgren, N. G., & Hardemark, H. G. (2007). Amphetamines for improving recovery after stroke. Cochrane Database Syst Rev.
4. Scheidtmann, K., Fries, W., Muller, F., & Koenig, E. (2001). Effect of levodopa in combination with physiotherapy on functional motor recovery after stroke: a prospective, randomised, double- blind study. Lancet, 358, 787-790
5. Scheidtmann, K. (2004). Advances in adjuvant pharmacotherapy for motor rehabilitation: effects of levodopa. Restor Neurol Neurosc, 22, 393-398.
6. Goldstein, L. B. (2006). Neurotransmitters and motor activity: effects on functional recovery after brain injury. NeuroRx, 4, 451-457.
7. Tombari, D., Ricciardi, M. C., Bonaffini, N., Pasquini, M., Cecconi, M., Di Piero, V., & Lenzi, G. L. (2006). Functional MRI, drugs, and poststroke recovery. Clin Exp Hypertension, 28, 301-307.
8. Berthier, M. L., Hinojosa, J., Martin, M. C., & Fernandez, I. (2003). Open-label study of donezepil in chronic post-stroke aphasia. Neurology, 60, 1218-1219.
9. Floel, A., Hummel, F., Breitenstein, C., Knecht, S. & Cohen, L. G. (2005). Dopaminergic effects on encoding of a motor memory in chronic stroke. Neurology, 65, 472-474.
10. Zittel, S., Weiler, C., & Liepert, J. (2007). Reboxetine improves motor function in chronic stroke. J Neurol, 254, 197-201.
11. Cohen, L. G., Ziemann, U., Chen, R., Classen, J., Hallett, M., Gerloff, C., & Butefisch, C. (1998). Studies of neuroplasticity with transcranial magnetic stimulation. J Clin Neurophysiol, 15, 305-324. [Review]. (Pubitemid 28402029)
12. Manganotti, P., Bongiovanni, L. G., Zanette, G., & Fiaschi, A. (1999). Cortical excitability in patients after loading doses of lam-otrigine: a brain magnetic stimulation study. Epilepsia, 40, 316-321.
13. Manganotti, P., Bortolomasi, M., Zanette, G., Pawelzik, T., Giacop-uzzi, M., & Fiaschi, A. (2001). Intravenous clomipramine decreases excitability of human motor cortex. A study with paired magnetic stimulation. J Neurol Sci, 184, 27-32. (Pubitemid 32166722)
14. Werhahn, K. J., Forderreuther, S., & Straube, A. (1998). Effects of the serotonin1B/1D receptor agonist zolmitriptan on motor cortical excitability in humans. Neurology, 51, 896-898.
15. Ziemann, U. (2004). TMS and drugs. Clin Neurophysiol, 115, 1717-1729. [Review].
16. Restemeyer, C., Weiller, C., & Liepert, J. (2007). No effect of a levodopa single dose on motor performance and motor excitability in chronic stroke. A double-blind placebo-controlled cross-over pilot study. Restor Neurol Neurosci, 25, 143-150.
17. Sonde, L., & Lokk, J. (2007). Effects of amphetamine and/or L-dopa and physiotherapy after stroke - a blinded randomized study. Acta Neurol Scan, 115, 55-59.
18. Priori, A., Berardelli, A., Inghilleri, M., Accornero, N., & Manfredi, M. (1994). Motor cortical inhibition and the dopaminergic system. Pharmacological changes in the silent period after transcranial brain stimulation in normal subjects, patients with Parkinson's disease and drug-induced parkinsonism. Brain, 117, 317-323
19. Lincoln, N., & Leadbitter, D. (1979). Assessment of motor function in stroke patients. Physiotherapy, 65, 48-51.
20. Wade, D. T. (1989). Measuring arm impairment and disability after stroke. Int Disabil Stud, 11, 89-92.
21. Wade, D. T., Wood, V. A., Heller, A., Maggs, J., & Langton Hewer, R. (1987). Walking after stroke. Measurement and recovery over the first 3 months. Scand J Rehabil Med, 19, 25-30. (Pubitemid 17039399)
22. Salkind, M. R. (1969). Beck depression inventory in general practice. J R Coll Gen Pract, 18, 267-271
23. Rossini, P. M., Barker, A. T., Berardelli, A., Caramia, M. D., Caruso, G., Cracco, R. Q., Dimitrijevic, M. R., Hallett, M., Kataya-ma, Y., Lucking, C. H., et al. (1994). Non-invasive electrical and magnetic stimulation of the brain, spinal cord and roots: basic principles and procedures for routine clinical application. Report of an IFCN committee. Electroencephalogr Clin Neurophysiol, 91, 79-92.
24. Lefaucher, J. P. (2005). Motor cortex dysfunction revealed by cortical excitability studies in Parkinson's disease: influence of antiparkinsonian treatment and cortical stimulation. Clin Neu-rophysiol, 116, 244-253. [Invited Review].
25. Cantello, R., Gianelli, M., Civardi, C., & Mutani, R. (1992). Magnetic brain stimulation: the silent period after the motor evoked potential. Neurology, 42, 1951-1959.
26. Strafella, A. P., Valzania, F., Nassetti, S. A., Tropeani, A., Bisulli, A., Santangelo & M., Tassinari, C. A. (2000). Effects of chronic levodopa and pergolide treatment on cortical excitability in patients with Parkinson's disease: a transcranial magnetic stimulation study. Clin Neurophysiol, 111, 1198-1202
27. Ziemann, U., Tergau, F., Bruns, D., Baudewig, J., & Paulus, W. (1997). Changes in human motor cortex excitability induced by dopaminergic and anti-dopaminergic drugs. Electroenc Clin Neurophysiol, 105, 430-437.
28. Beauregard, M., & Ferron, A. (1991). Dopamine modulates the inhibition induced by GABA in rat cerebral cortex: an ion-tophoretic study. Eur J Pharmacol, 205, 225-231.
29. Cantello, R., Tarletti, R., & Civardi, C. (2002). Transcranial magnetic stimulation and Parkinson's disease. Brain Res Brain Res Rev, 38, 309-327 (Pubitemid 34219109)
30. Groenewegen, H. J. (2003). The basal ganglia and motor control. Neural Plasticity, 10, 107-120.
31. Visser, J. E., & Bloem, B. R. (2005). Role of the basal ganglia in balance control. Neural Plasticity, 12, 161-174.
32. Manganotti P,., Patuzzo S., Cortese F., Palermo A., Smania N., & Fiaschi A. (2002). Motor disinhibition in affected and unaffected hemisphere in the early period of recovery after stroke. Clin Neurophysiol, 113, 936-943.
33. Manganotti, P., Acler, M., Zanette, G. P., Smania, N., & Fiaschi, A. (2008). Motor cortical disinhibition during early and late recovery after stroke. Neurorehabil Neural Repair, 22, 396-403.
34. Fregni, F., & Pascual-Leone, A. (2007). Technology insight: non-invasive brain stimulation in neurology-perspectives on the therapeutic potential of rTMS and tDCS. Nat Clin Pract Neurol 3, 383-393.
35. Liepert, J., Uhde, I., Graf, S., Leidner, O., & Weiller, C. (2001). Motor cortex plasticity during forced use therapy in stroke patients. J Neurol, 248, 315-321.